Add BrightSurf on Google Email

Adulting is hard on the heart: Teen to young adulthood is a critical time to address risk

Many teenagers enter adulthood with significant risk factors for cardiovascular disease, and emerging adulthood is a key time to address these risks. Interventions such as health practices, lifestyle changes, and improved access to healthcare can help reduce the risk of developing future cardiovascular disease.

SourceAmerican Heart Association·JournalJournal of the American Heart Association·DateMar 26, 2025

Why some breast cancer treatments stop working

A new review highlights how breast cancer cells change their communication and growth patterns, helping tumors survive, spread, and resist treatment. The review explores disrupted signaling pathways, including PI3K/Akt/mTOR and RAS/RAF/MEK/ERK, which can promote tumor progression and resistance to treatment.

SourceImpact Journals LLC·JournalOncotarget·TypeSystematic review·DateMar 25, 2025

Computational drug discovery: Exploring natural products targeting SARS-CoV-2

A recent study identifies 11 natural compounds that can inhibit the SARS-CoV-2 spike protein, including caffeine, which exhibits high binding stability and excellent solubility. The discovery highlights the potential of natural products in combating COVID-19 and demonstrates the versatility of widely known compounds like caffeine.

SourceNara Institute of Science and Technology·JournalScientific Reports·TypeComputational simulation/modeling·DateMar 20, 2025

Efficient development of drugs with fewer mice

Researchers at the University of Zurich have developed a technology to test 25 antibodies simultaneously in a single mouse, greatly reducing the number of laboratory animals required. The method uses protein fragments as barcodes for analysis, allowing for high-quality preclinical data on multiple antibody candidates.

SourceUniversity of Zurich·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateMar 18, 2025

Aligning Science Across Parkinson’s (ASAP) launches a second funding opportunity to accelerate novel tool development to advance Parkinson's disease research

The Aligning Science Across Parkinson’s (ASAP) initiative offers funding of up to $6M for research community members to develop sustainable tools for Parkinson’s disease research. The funding supports the development of preclinical models, detection reagents, and modulation agents to accelerate therapeutic research.

Pusan National University researchers developed an advanced AI model for accelerating therapeutic gene target discovery

The new AI model leverages hypergraphs to quickly and accurately identify therapeutic gene targets for diseases. HIT outperformed existing models in all tested metrics, demonstrating its accuracy in classifying therapeutic gene targets with great precision.

SourcePusan National University·JournalBriefings in Bioinformatics·TypeComputational simulation/modeling·DateMar 5, 2025

Innovations in core-shell nanoparticles advancing drug delivery and precision medicine

Core-shell nanoparticles offer effective drug encapsulation, shielding from degradation, and controlled release. This innovation enables targeted drug delivery, improving treatment outcomes and reducing side effects. The versatility of these nanoparticles allows for tailored materials to suit different therapeutic needs.

SourceMary Ann Liebert, Inc./Genetic Engineering News·JournalOMICS A Journal of Integrative Biology·TypeLiterature review·DateMar 5, 2025

New combination treatment strategy dramatically increases cell death in leukemia

Researchers at VCU Massey Comprehensive Cancer Center have identified an innovative combination treatment strategy that collaborates to kill AML cells. The new approach targets the SRC gene and MCL-1 protein, leading to increased cell death in leukemia cells. This discovery offers a promising new direction for leukemia treatment.

SourceVirginia Commonwealth University·JournalSignal Transduction and Targeted Therapy·TypeMeta-analysis·DateFeb 27, 2025

Biologists transform gut bacteria into tiny protein pharmacies

Researchers at Virginia Tech have developed a method to convert gut bacteria into mini protein factories that produce and release sustained flows of targeted proteins within the lower intestine. This approach eliminates a major roadblock in delivering drugs to this part of the body, offering potential treatment for chronic diseases.

SourceVirginia Tech·JournalNature·DateFeb 18, 2025

New study suggests panitumumab with low-dose capecitabine as a safer, effective maintenance treatment for advanced colorectal cancer

Researchers found that a combination of Panitumumab and low-dose Capecitabine is an effective and well-tolerated maintenance regimen for patients with wild-type KRAS metastatic colorectal cancer. The treatment delayed disease progression while managing side effects, improving patients' quality of life.

SourceImpact Journals LLC·JournalOncotarget·TypeNews article·DateFeb 18, 2025

Beyond the gut: A new frontier in IBS treatment by targeting the brain

Researchers at Tokyo University of Science have found that opioid delta-receptor agonists can alleviate stress-induced IBS symptoms in a validated mouse model by targeting the central nervous system. The study suggests that these drugs could provide a more definitive solution for IBS with minimal adverse effects.

SourceTokyo University of Science·JournalBritish Journal of Pharmacology·TypeExperimental study·DateFeb 5, 2025

Cutting back on alcohol may be more effective than immediately abstaining for preventing misuse among college students

A Texas A&M University researcher found that reducing alcohol consumption aligns with a harm reduction approach, which may be a more feasible approach for high-risk college drinkers. The study surveyed 822 high-risk college students and analyzed their intention to reduce drinking using the Theory of Planned Behavior.

SourceTexas A&M University·JournalAmerican Journal of Health Education·DateJan 30, 2025

NUS researchers pioneer DNA-tagged gold nanoparticles for targeted cancer treatment

The team's novel technique enables high-throughput screening of nanoparticle shapes, sizes, and modifications, reducing associated screening costs. The research demonstrates the distinct preferences of tumour cells for certain nanoparticle configurations, enabling personalized cancer treatments that are safer and more effective.

SourceNational University of Singapore·JournalAdvanced Functional Materials·TypeExperimental study·DateJan 27, 2025